Meeting
2011 ASCO Annual Meeting
Long-term results of the Toronto magnetic resonance imaging (MRI) breast surveillance study of women with BRCA1 or BRCA2 mutations.
Authors
K. Passaperuma
Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
K. Passaperuma , D. B. Plewes , P. Causer , K. A. Hill , S. J. Messner , J. Wong , R. A. Jong , F. Wright , M. Yaffe , E. Ramsay , S. Balasingham , L. Verity , A. Eisen , B. Curpen , R. Shumak , S. Narod , E. Warner
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer - HER2/ER
Track
Breast Cancer
Sub Track
Prevention
Citation
J Clin Oncol 29: 2011 (suppl; abstr 542)
Abstract #
542
Poster Bd #
1F
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
The incidence and impact of brain metastasis in patients with hereditary BRCA1/2 mutated invasive breast cancer in a prospectively followed cohort.
First Author: Haven Garber
Poster
2018 ASCO Annual Meeting
"What if I keep my breasts?" Extended follow-up of unaffected BRCA mutation carriers diagnosed with breast cancer (BC) in the Toronto magnetic resonance imaging (MRI) screening study.
First Author: Ellen Warner
Poster
2012 Breast Cancer Symposium
Breast cancer detection among Irish BRCA1 and BRCA2 mutation carriers.
First Author: Elaine Walsh
Poster
2019 ASCO Annual Meeting
Brain metastasis in patients with hereditary BRCA-mutated invasive breast cancer.
First Author: Haven Garber